← FDA DRUG APPROVALS
FDA NDA · NDA018229
DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Sponsor: B BRAUN
APPLICATION
NDA018229
TYPE
NDA
ORIGINAL APPROVAL
1979-06-28
LATEST ACTION
1990-09-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERDiscontinued
DEXTROSE 10GM/100ML, SODIUM CHLORIDE 450MG/100ML · INJECTABLE · INJECTION
Approval history
1990-09-11Manufacturing (CMC) · Supplement 14 · standardAP
1986-02-18Manufacturing (CMC) · Supplement 9 · standardAP
1985-08-02Labeling · Supplement 12 · standardAP
1985-06-28Manufacturing (CMC) · Supplement 10 · standardAP
1985-04-03Manufacturing (CMC) · Supplement 11 · standardAP
1983-01-24Labeling · Supplement 6 · standardAP
1981-10-26Manufacturing (CMC) · Supplement 8 · standardAP
1981-03-18Manufacturing (CMC) · Supplement 7 · standardAP
1980-08-06Manufacturing (CMC) · Supplement 4 · standardAP
1980-02-12Manufacturing (CMC) · Supplement 3 · standardAP
1979-10-16Manufacturing (CMC) · Supplement 1 · standardAP
1979-10-09Labeling · Supplement 2 · standardAP
1979-06-28Type 5 - New Formulation or New Manufacturer · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.